Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 26;11(1):11084.
doi: 10.1038/s41598-021-90548-1.

Comprehensive profiling analysis of the N6-methyladenosine-modified circular RNA transcriptome in cultured cells infected with Marek's disease virus

Affiliations

Comprehensive profiling analysis of the N6-methyladenosine-modified circular RNA transcriptome in cultured cells infected with Marek's disease virus

Aijun Sun et al. Sci Rep. .

Abstract

Marek's disease virus (MDV) induces severe immunosuppression and lymphomagenesis in the chicken, its natural host, and results in a condition that investigated the pathogenesis of MDV and have begun to focus on the expression profiling of circular RNAs (circRNAs). However, little is known about how the expression of circRNAs is referred to as Marek's disease. Previous reports have is regulated during MDV replication. Here, we carried out a comprehensive profiling analysis of N6-methyladenosine (m6A) modification on the circRNA transcriptome in infected and uninfected chicken embryonic fibroblast (CEF) cells. Methylated RNA immunoprecipitation sequencing (MeRIP-Seq) revealed that m6A modification was highly conserved in circRNAs. Comparing to the uninfected group, the number of peaks and conserved motifs were not significantly different in cells that were infected with MDV, although reduced abundance of circRNA m6A modifications. However, gene ontology and Kyoto encyclopedia of genes and genomes (KEGG) pathway analyses revealed that the insulin signaling pathway was associated with the regulation of m6A modified circRNAs in MDV infection. This is the first report to describe alterations in the transcriptome-wide profiling of m6A modified circRNAs in MDV-infected CEF cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flowchart depicting construction of cDNA libraries used for m6A-modified circRNA transcriptome sequencing of uninfected and Md5-infected CEF cells. (Figure was made by Adobe Illustrator, v 24.0, https://www.adobe.com/cn/products/illustrator.html).
Figure 2
Figure 2
(A) Differentially expressed circRNAs in infected and control groups. The X axis represents the expression level of the gene in the control group, and the Y axis represents the expression level of the gene in the infected group. A represents the uninfected group and B represents the infected group. Red dots represent up-regulated genes in group B compared with group A. Green dots represent down-regulated genes in group B compared with group A. Blue dots represent genes with no significant differences in group B compared with group A. (Made by edgeR, v3.16.5, http://www.bioconductor.org/packages/release/bioc/html/edgeR.html) (B,C) GO enrichment of host genes associated with down-regulated circRNAs for (B) biological processes and (C) molecular functions; (D) KEGG pathway analysis of the host genes for circRNAs.
Figure 3
Figure 3
The characteristics of m6A peaks. (A) Venn diagram of m6A genes in infected Md5 and CEF groups; (B) Venn diagram of m6A methylation sites identified in circRNAs from infected and CEF groups; (C) The sequence motif of m6A sites in infected and control groups (Made by Discriminative Regular Expression Motif Elicitation (DREME), v5.3.3, https://meme-suite.org/meme/tools/dreme); (D) Proportion of genes harboring different numbers of m6A sites in the two groups (Made by Prism, v8.0.2, https://www.graphpad.com).
Figure 4
Figure 4
m6A modification clustering analysis. (A) Cluster analysis of m6A methylation at the transcriptome level. (B) Cluster analysis of m6A m6A modified lncRNA genes in the infected and control groups. The color represents the size of the log-fold enrichment (FE) value: the closer the color is to red, the larger the logFE value. Md5-1, Md5-2, Md5-3 represent the Md5-infected CEF group with three independent replicates. ( Made by Tbtools, v1.082, http://www.tbtools.org).
Figure 5
Figure 5
Chromosome visualization of m6A sites in lncRNAs. Red represents the infected group while blue represents the control group. Md5-1, Md5-2, Md5-3 represent the Md5-infected CEF group with three independent replicates. Differentially methylated m6A peaks visualized in Md5-infected group and control group. The highlighted area represents one of the differential methylation peaks.
Figure 6
Figure 6
Gene ontology analyses of the infected and control groups. (A) The top ten gene ontology terms of biological processes were significantly enriched for the up-regulated genes; (B) The top seven gene ontology terms of cell component were significantly enriched for the up-regulated genes; (C) The top ten gene ontology terms of molecular functions were significantly enriched for the up-regulated genes; (D) The top ten gene ontology terms of biological process significantly enriched for down-regulated genes; (E) The top five gene ontology terms of molecular functions significantly enriched for down-regulated genes.
Figure 7
Figure 7
KEGG pathway analysis of differentially methylated m6A genes in circRNAs. (A) Bar plot showing the top 10 enrichment scores of significantly enriched pathways for up-methylated m6A genes in the infected group; (B) Bar plot showing the top 10 enrichment scores of significantly enriched pathways for down-methylated m6A genes in the infected group.

Similar articles

Cited by

References

    1. Biggs PM, Nair V. The long view: 40 years of Marek's disease research and Avian Pathology. Avian Pathol. 2012;41:3–9. doi: 10.1080/03079457.2011.646238. - DOI - PubMed
    1. Jarosinski KW, Tischer BK, Trapp S, Osterrieder N. Marek's disease virus: lytic replication, oncogenesis and control. Expert Rev Vaccines. 2006;5:761–772. doi: 10.1586/14760584.5.6.761. - DOI - PubMed
    1. Calnek BW. Pathogenesis of Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 2001;255:25–55. doi: 10.1007/978-3-642-56863-3_2. - DOI - PubMed
    1. Schumacher D, Tischer BK, Fuchs W, Osterrieder N. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 2000;74:11088–11098. doi: 10.1128/jvi.74.23.11088-11098.2000. - DOI - PMC - PubMed
    1. Lee LF, et al. The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc. Natl. Acad. Sci. U S A. 2000;97:6091–6096. doi: 10.1073/pnas.97.11.6091. - DOI - PMC - PubMed

Publication types